References
Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost 4:295–306
Finazzi G, Marchioli R, Brancaccio V et al (2005) A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost 3:848–853
Patrono C, Coller B, FitzGerald GA et al (2004) Platelet-active drugs: the relationship among dose, effectiveness and side effects. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:234S–264S
Landolfi R, Marchioli R, Kutti J et al (2004) Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 350:114–124
Giron-Gonzales JA, Garcia del Rio E, Rodriguez C et al (2004) Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 31:1560–1567
Forastiero R, Martinuzzo M, Pombo G et al (2005) A prospective study of antibodies to β2-glycoprotein I and prothrombin and risk of thrombosis. J Thromb Haemost 3:1231–1238
Shah NM, Khamashta MA, Atsumi T et al (1998) Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. Lupus 7:3–6
Somers E, Magder LS, Petri M (2002) Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol 29:2531–2536
Finazzi G, Brancaccio V, Moia M et al (1996) Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies. A four-year prospective study from the Italian registry. Am J Med 100:530–536
Khamashta MA, Cuadrado MJ, Mujic F et al (1995) The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 332:993–997
Kaul M, Erkan D, Sammaritano L et al (2007) Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Ann Rheum Dis 66:927–930
Ginsburg KS, Liang MH, Newcomer L et al (1992) Anticardiolipn antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med 117:997–1002
Wahl DG, Bounameaux H, de Moerloose P et al (2000) Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis. Arch Intern Med 160:2042–2048
Erkan D, Harrison MJ, Levy R et al (2007) Aspirin for primary thrombosis prevention in the antiphospholipid syndrome. Arthritis Rheum 56:2382–2391
Galli M, Borrelli G, Jacobsen EM et al (2007) Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood 110:1178–1183
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Finazzi, G. Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No. Intern Emerg Med 3, 197–200 (2008). https://doi.org/10.1007/s11739-008-0169-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11739-008-0169-4